These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 18456759)
1. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Glimelius B; Oliveira J; Ann Oncol; 2008 May; 19 Suppl 2():ii31-2. PubMed ID: 18456759 [No Abstract] [Full Text] [Related]
2. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Glimelius B; Tiret E; Cervantes A; Arnold D; Ann Oncol; 2013 Oct; 24 Suppl 6():vi81-8. PubMed ID: 24078665 [No Abstract] [Full Text] [Related]
3. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer. Tveit KM; Kataja VV; Ann Oncol; 2005; 16 Suppl 1():i20-1. PubMed ID: 15888739 [No Abstract] [Full Text] [Related]
4. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer. Tveit KM; Ann Oncol; 2003 Jul; 14(7):1006-7. PubMed ID: 12853337 [No Abstract] [Full Text] [Related]
5. Rectal Cancer in 2018: A Primer for the Gastroenterologist. Goldenberg BA; Holliday EB; Helewa RM; Singh H Am J Gastroenterol; 2018 Dec; 113(12):1763-1771. PubMed ID: 30008472 [No Abstract] [Full Text] [Related]
6. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Glimelius B; Påhlman L; Cervantes A; Ann Oncol; 2010 May; 21 Suppl 5():v82-6. PubMed ID: 20555109 [No Abstract] [Full Text] [Related]
7. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Glynne-Jones R; Wyrwicz L; Tiret E; Brown G; Rödel C; Cervantes A; Arnold D; Ann Oncol; 2017 Jul; 28(suppl_4):iv22-iv40. PubMed ID: 28881920 [No Abstract] [Full Text] [Related]
14. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. Church JM ANZ J Surg; 2002 Jul; 72(7):460. PubMed ID: 12123497 [No Abstract] [Full Text] [Related]
15. Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Kataja V; Castiglione M; Ann Oncol; 2008 May; 19 Suppl 2():ii11-3. PubMed ID: 18456744 [No Abstract] [Full Text] [Related]
16. Risk factors of rectal cancer local recurrence: population-based survey and validation of the Swedish rectal cancer registry. Jörgren F; Johansson R; Damber L; Lindmark G Colorectal Dis; 2010 Oct; 12(10):977-86. PubMed ID: 19438885 [TBL] [Abstract][Full Text] [Related]
18. Treatment options for advanced pelvic recurrence of rectal cancer. Longo WE Int J Surg Investig; 1999; 1(3):252-3. PubMed ID: 11341618 [No Abstract] [Full Text] [Related]
19. [Treatment of rectal cancer and follow up]. Charúa-Guindic L Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():126-31. PubMed ID: 18277500 [No Abstract] [Full Text] [Related]
20. [Treatment strategy and pattern evaluation of 314 patients with recurrence of rectal cancer]. Liu YL; Yang YM; Wang XS Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Aug; 13(8):572-6. PubMed ID: 20737306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]